ARCHIVES

Get the latest industry insights.

Quality people. Great service. Responsive. Professional.

Tag: R&D

New Study Finds Freenome’s Multiomics Approach Successful in Detecting Pancreatic Cancer

New Study Finds Freenome’s Multiomics Approach Successful in Detecting Pancreatic Cancer

Via: https://www.biospace.com/article/releases/new-study-finds-freenome-s-multiomics-approach-successful-in-detecting-pancreatic-cancer/ Published: Sep 29, 2021 SOUTH SAN FRANCISCO, Calif., Sept. 29, 2021 /PRNewswire/ — Freenome, a privately-held biotech company, presented new research today at the American Association of Cancer Research (AACR) Special Conference on Pancreatic Cancer. The data

Read More »
Now Hiring

Clinical Catch-Up: July 12-16

Published: Jul 19, 2021 By Mark Terry Via: https://www.biospace.com/article/clinical-catch-up-july-12-16/ It was a moderately busy mid-summer week for clinical trial news. Here’s a look. COVID-19-Related ARCA biopharma provided an update on its Phase IIb ASPEN-COVID-19 trial of rNAPc2

Read More »
BioAge Picks Up Muscle-Aging Program From Amgen

BioAge Licenses Amgen Drug To Treat Muscle Aging

Via: https://www.fiercebiotech.com/biotech/bioage-picks-up-muscle-aging-program-from-amgen-bringing-pipeline-count-to-3 BioAge Labs is adding a third program to its pipeline. The new treatment, licensed from Amgen, is designed to combat muscle aging and could be useful in helping older people recover from surgery

Read More »